Everjoy Health Group Co.,Ltd. (SHE:002162)
China · Delayed Price · Currency is CNY 4.430
-0.040 (-0.89%)
May 6, 2026, 3:04 PM CST
Everjoy Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 993.98 | 979.12 | 1,124 | 1,192 | 1,077 | 1,184 |
Other Revenue | 82.76 | 82.76 | 80.3 | 85.7 | 85.24 | 77 |
| 1,077 | 1,062 | 1,204 | 1,278 | 1,163 | 1,261 | |
Revenue Growth (YoY) | -8.66% | -11.82% | -5.79% | 9.94% | -7.79% | 5.54% |
Cost of Revenue | 825.85 | 820.2 | 961.34 | 1,012 | 972.63 | 927.3 |
Gross Profit | 250.88 | 241.67 | 242.8 | 266.55 | 190 | 333.53 |
Selling, General & Admin | 205.66 | 205.23 | 241.25 | 250.68 | 242.47 | 235.67 |
Research & Development | 5.92 | 6.16 | 7.92 | 10.21 | 11.69 | 13.48 |
Other Operating Expenses | 10.58 | 11.1 | 11.1 | 13.36 | 12.5 | 14.02 |
Operating Expenses | 218.66 | 218.99 | 295.8 | 331.6 | 315.5 | 269.53 |
Operating Income | 32.22 | 22.69 | -52.99 | -65.05 | -125.5 | 64 |
Interest Expense | -21.84 | -21.84 | -23.9 | -27.04 | -30.06 | -34.16 |
Interest & Investment Income | 5.89 | 5.92 | 5.07 | 167.98 | 3.4 | 2.08 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.06 | -0.02 | 0.04 | -0.02 |
Other Non Operating Income (Expenses) | 0.24 | 0.36 | -1.45 | -22.19 | -28.8 | -0.64 |
EBT Excluding Unusual Items | 16.53 | 7.13 | -73.22 | 53.69 | -180.92 | 31.27 |
Impairment of Goodwill | - | - | -17.07 | - | -42.58 | - |
Gain (Loss) on Sale of Investments | 3.85 | 4.79 | -5.84 | -0.73 | -9.87 | 17.51 |
Gain (Loss) on Sale of Assets | -1.35 | -2.46 | 0.28 | -3.16 | -64.01 | -8.2 |
Asset Writedown | -9.01 | -4.79 | -15.9 | -20.56 | -11.49 | - |
Other Unusual Items | 4.44 | 4.44 | 0.33 | 10.18 | 8.03 | 7.21 |
Pretax Income | 14.47 | 9.11 | -111.42 | 39.42 | -300.84 | 47.79 |
Income Tax Expense | 2.94 | 3.14 | 38.6 | -8.61 | -20.57 | 0.02 |
Earnings From Continuing Operations | 11.53 | 5.97 | -150.02 | 48.03 | -280.27 | 47.77 |
Minority Interest in Earnings | 0.16 | 0.75 | 2.9 | 2.03 | 2.43 | -1.6 |
Net Income | 11.69 | 6.73 | -147.12 | 50.06 | -277.84 | 46.17 |
Net Income to Common | 11.69 | 6.73 | -147.12 | 50.06 | -277.84 | 46.17 |
Net Income Growth | - | - | - | - | - | -19.27% |
Shares Outstanding (Basic) | 918 | 922 | 922 | 927 | 926 | 890 |
Shares Outstanding (Diluted) | 918 | 922 | 922 | 927 | 926 | 890 |
Shares Change (YoY) | -0.57% | -0.10% | -0.51% | 0.07% | 4.14% | 4.21% |
EPS (Basic) | 0.01 | 0.01 | -0.16 | 0.05 | -0.30 | 0.05 |
EPS (Diluted) | 0.01 | 0.01 | -0.16 | 0.05 | -0.30 | 0.05 |
EPS Growth | - | - | - | - | - | -22.54% |
Free Cash Flow | 48.9 | 32.17 | 50.61 | 74.1 | -13.63 | 119.09 |
Free Cash Flow Per Share | 0.05 | 0.04 | 0.06 | 0.08 | -0.01 | 0.13 |
Gross Margin | 23.30% | 22.76% | 20.16% | 20.85% | 16.34% | 26.45% |
Operating Margin | 2.99% | 2.14% | -4.40% | -5.09% | -10.79% | 5.08% |
Profit Margin | 1.09% | 0.63% | -12.22% | 3.92% | -23.90% | 3.66% |
Free Cash Flow Margin | 4.54% | 3.03% | 4.20% | 5.80% | -1.17% | 9.45% |
EBITDA | 57.37 | 50.44 | -14.79 | -19.89 | -68.86 | 124.46 |
EBITDA Margin | 5.33% | 4.75% | -1.23% | -1.56% | -5.92% | 9.87% |
D&A For EBITDA | 25.15 | 27.76 | 38.2 | 45.16 | 56.64 | 60.46 |
EBIT | 32.22 | 22.69 | -52.99 | -65.05 | -125.5 | 64 |
EBIT Margin | 2.99% | 2.14% | -4.40% | -5.09% | -10.79% | 5.08% |
Effective Tax Rate | 20.31% | 34.44% | - | - | - | 0.04% |
Revenue as Reported | 1,062 | 1,062 | 1,204 | 1,278 | 1,163 | 1,261 |
Advertising Expenses | - | 22.79 | 31.93 | 32.69 | 30.32 | 27.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.